Lupin first-quarter profit slumps, misses estimates Ruby Khatun Khatun4 Aug 2017 9:15 AM ISTDrugmaker Lupin Ltd said on Wednesday first quarter profit fell 59 percent, well below analysts' estimates, as regulatory hurdles and pricing pressure...
Chinese firm plan to buy Gland Pharma faces CCEA objections Ruby Khatun Khatun4 Aug 2017 9:14 AM ISTNew Delhi: The CCEA has raised objections to the Rs 8,800 crore proposal of Chinese pharma firm Shanghai Fosun to acquire majority stake in domestic...
Lupin Aurangabad plant undergoes USFDA inspection Ruby Khatun Khatun3 Aug 2017 9:21 AM ISTNew Delhi: Drug major Lupin on Monday said the US health regulator has completed the prior approval inspection (PAI) of its Aurangabad manufacturing...
Alembic Pharma gets USFDA go-ahead for anti-bacterial drug Ruby Khatun Khatun3 Aug 2017 9:20 AM ISTNew Delhi: Drug firm Alembic Pharmaceuticals has received the US health regulator's nod for anti-bacterial Doxycycline capsules."The company has...
Glenmark Pharma releases investigational skin findings Ruby Khatun Khatun3 Aug 2017 9:17 AM ISTNew Delhi: Drug major Glenmark Pharmaceuticals on Tuesday came out with positive findings from phase 2 a study of GBR 830, an investigational...
After perfect storm, Dr Reddy's seeks recovery this fiscal Ruby Khatun Khatun3 Aug 2017 9:16 AM ISTNew Delhi: After facing a "perfect storm" of adverse developments, Dr Reddy's Laboratories expects better financial performance this fiscal with cost...
Key drug sales push Pfizer profit up 50 percent Ruby Khatun Khatun3 Aug 2017 9:15 AM ISTRising sales of key drugs, lower one-time charges and reduced manufacturing costs helped drive Pfizer's profit up 50 percent in the second quarter.The...
AstraZeneca a tricky takeover target after big cancer drug blow Ruby Khatun Khatun3 Aug 2017 9:14 AM ISTLONDON: Hurdles ranging from existing commercial tie-ups to politics make drugmaker AstraZeneca a problematic takeover target in the wake of last...
Cipla eyes filing over 20 ANDAs in US this fiscal Ruby Khatun Khatun2 Aug 2017 9:25 AM ISTNew Delhi: Drug major Cipla has said it is looking to file more than 20 applications seeking approval for its generic medicines from the US health...
A National Steering Committee constituted to initiate a Scientific Validation, Research Ruby Khatun Khatun2 Aug 2017 9:22 AM ISTThe Department of Science and Technology (DST), Government of India has constituted a National Steering Committee to initiate a National Programme on...
Sanofi raises outlook but key eczema drug disappoints investors Ruby Khatun Khatun2 Aug 2017 9:20 AM ISTPARIS: Sanofi raised its 2017 earnings forecast on the back of strong growth in the second quarter but investors were disappointed with sales of key...
AstraZeneca lung cancer failure sparks 16 percent share fall Ruby Khatun Khatun2 Aug 2017 9:18 AM ISTLONDON: AstraZeneca's combination of two injectable immunotherapy drugs failed to help patients as hoped in a closely watched advanced lung cancer...
